Heartflow (NASDAQ:HTFL) Hits New 12-Month High - Here's Why

Key Points

• Heartflow shares reached a new 52-week high of $51.36, up from a prior close of $50.43, giving the company a market capitalization of approximately $4.37 billion.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $43.43; Canaccord Genuity and Stifel both raised their targets to $45.
• Heartflow reported stronger-than-expected quarterly results, including an adjusted loss of $0.07 per share versus an expected loss of $0.22 and revenue growth of 47.7% year over year, though the company remains unprofitable.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $51.36 and last traded at $51.2120, with a volume of 76614 shares. The stock had previously closed at $50.43.

Analysts Set New Price Targets

A number of research firms have recently commented on HTFL. Weiss Ratings upgraded Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 7th. Canaccord Genuity Group increased their price objective on shares of Heartflow from $37.00 to $45.00 and gave the company a "buy" rating in a research report on Friday, August 14th. Stifel Nicolaus lifted their price objective on Heartflow from $40.00 to $45.00 and gave the stock a "buy" rating in a report on Friday, August 14th. Freedom Capital upgraded Heartflow to a "strong-buy" rating in a research report on Tuesday, June 30th. Finally, Benchmark reissued a "buy" rating on shares of Heartflow in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Heartflow presently has an average rating of "Moderate Buy" and a consensus target price of $43.43.

Heartflow Stock Performance

The firm has a market capitalization of $4.37 billion and a PE ratio of -27.51. The business's fifty day simple moving average is $32.90 and its 200-day simple moving average is $29.39.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The company's quarterly revenue was up 47.7% on a year-over-year basis. Sell-side analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Transactions at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares in the company, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the business's stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer directly owned 457,935 shares in the company, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 191,271 shares of company stock valued at $7,089,136. 7.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the 4th quarter valued at $27,000. Russell Investments Group Ltd. purchased a new position in Heartflow in the fourth quarter worth $45,000. Legal & General Group Plc purchased a new stake in shares of Heartflow during the third quarter worth about $59,000. Essential Partners LLC purchased a new position in shares of Heartflow in the first quarter worth $57,000. Finally, Strs Ohio purchased a new stake in Heartflow during the 4th quarter valued at about $99,000.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.